soojeong jo

Dr. soojeong jo

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2024 in Investigative and Clinical Urology
Verified
Journal Article
Open access
PDF file
KKKyeong Kim
Kyeong Kim
YBYoung Joon Byun
Young Joon Byun
CZChuang-Ming Zheng
Chuang-Ming Zheng
SMSungmin Moon
Sungmin Moon
SJsoojeong jo
soojeong jo
SYSeok Joong Yun
Seok Joong Yun
Kim K, et al. Investig Clin Urol. 2024 Jan;65(1):94-103. https://doi.org/10.4111/icu.20230227

15 August 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
SJsoojeong jo
soojeong jo
SLSo-Hee Lee
So-Hee Lee
HMHyo-Jin Min
Hyo-Jin Min
HKHee-Ji Kim
Hee-Ji Kim
HKHyun Ho Kong
Hyun Ho Kong
Background/Objectives: Hospital-associated disability (HAD), a functional decline following acute hospitalization, is a common complication associated with mortality and unfavorable prognoses in patients admitted to acute care hospitals. However, few studies have investigated mortality and associated factors in patients with HAD and have been limited by inconsistent HAD assessment tools and criteria. This study investigated mortality and risk factors in patients with HAD using specific criteria. Methods: This retrospective study evaluated patients referred to the Department of Rehabilitation Medicine with suspected HAD between June 2022 and March 2023. The collected data included medical histories, diagnostic tests for HAD (including muscle strength, balance, and modified Barthel Index), and bioelectrical impedance analysis (BIA). Multivariate logistic regression analysis was conducted to identify factors associated with mortality. Kaplan–Meier survival curves were constructed for mortality at 3 and 7 months. Results: A total of 455 patients were identified, among which 206 patients diagnosed with HAD (73.1 ± 12.5 years) were included in the analysis. The 3-month mortality rate was 27.2%. In the multivariate analysis, male sex (odds ratio (OR), 3.23; p < 0.01), a history of cancer (OR, 2.18; p < 0.05), and a low phase angle (OR, 0.69; p < 0.05) were significantly associated with mortality. A phase angle < 2.9° on BIA was associated with a significant increase in 3-month (hazard ratio (HR), 1.85; 95% confidence interval (CI), 1.06–3.23) and 7-month (HR, 2.80; 95% CI, 1.75–4.98) mortality. Conclusions: Patients with HAD had a high mortality rate, with several factors, particularly low BIA phase angles, associated with increased mortality.